Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility gene

X. J. Luo, M. Li, L. Huang, S. Steinberg, M. Mattheisen, G. Liang, G. Donohoe, Y. Shi, C. Chen, W. Yue, A. Alkelai, B. Lerer, Z. Li, Q. Yi, M. Rietschel, S. Cichon, D. A. Collier, S. Tosato, J. Suvisaari, Dan Rujescu & 21 others V. Golimbet, T. Silagadze, N. Durmishi, M. P. Milovancevic, H. Stefansson, T. G. Schulze, M. M. Nöthen, C. Chen, R. Lyne, D. W. Morris, M. Gill, A. Corvin, D. Zhang, Q. Dong, R. K. Moyzis, K. Stefansson, E. Sigurdsson, F. Hu, Consortium36 SCZ Consortium36, B. Su, L. Gan

Research output: Contribution to journalArticle

Abstract

Genes that are differentially expressed between schizophrenia patients and healthy controls may have key roles in the pathogenesis of schizophrenia. We analyzed two large-scale genome-wide expression studies, which examined changes in gene expression in schizophrenia patients and their matched controls. We found calcium/calmodulin (CAM)-dependent protein kinase kinase 2 (CAMKK2) is significantly downregulated in individuals with schizophrenia in both studies. To seek the potential genetic variants that may regulate the expression of CAMKK2, we investigated the association between single-nucleotide polymorphisms (SNPs) within CAMKK2 and the expression level of CAMKK2. We found one SNP, rs1063843, which is located in intron 17 of CAMKK2, is strongly associated with the expression level of CAMKK2 in human brains (P=1.1 × 10-6) and lymphoblastoid cell lines (the lowest P=8.4 × 10-6). We further investigated the association between rs1063843 and schizophrenia in multiple independent populations (a total of 130 623 subjects) and found rs1063843 is significantly associated with schizophrenia (P=5.17 × 10 -5). Interestingly, we found the T allele of rs1063843, which is associated with lower expression level of CAMKK2, has a higher frequency in individuals with schizophrenia in all of the tested samples, suggesting rs1063843 may be a causal variant. We also found that rs1063843 is associated with cognitive function and personality in humans. In addition, protein-protein interaction (PPI) analysis revealed that CAMKK2 participates in a highly interconnected PPI network formed by top schizophrenia genes, which further supports the potential role of CAMKK2 in the pathogenesis of schizophrenia. Taken together, these converging lines of evidence strongly suggest that CAMKK2 may have pivotal roles in schizophrenia susceptibility.

Original languageEnglish (US)
Pages (from-to)774-783
Number of pages10
JournalMolecular Psychiatry
Volume19
Issue number7
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Protein Kinases
Schizophrenia
Phosphotransferases
Genes
Single Nucleotide Polymorphism
Calcium-Calmodulin-Dependent Protein Kinase Kinase
Protein Interaction Maps
Proteins
Introns
Cognition
Personality
Down-Regulation
Alleles
Genome
Gene Expression
Cell Line
Brain

Keywords

  • association
  • CAMKK2
  • eQTL
  • expression
  • protein-protein interaction
  • schizophrenia

ASJC Scopus subject areas

  • Molecular Biology
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience

Cite this

Luo, X. J., Li, M., Huang, L., Steinberg, S., Mattheisen, M., Liang, G., ... Gan, L. (2014). Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility gene. Molecular Psychiatry, 19(7), 774-783. https://doi.org/10.1038/mp.2013.103

Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility gene. / Luo, X. J.; Li, M.; Huang, L.; Steinberg, S.; Mattheisen, M.; Liang, G.; Donohoe, G.; Shi, Y.; Chen, C.; Yue, W.; Alkelai, A.; Lerer, B.; Li, Z.; Yi, Q.; Rietschel, M.; Cichon, S.; Collier, D. A.; Tosato, S.; Suvisaari, J.; Rujescu, Dan; Golimbet, V.; Silagadze, T.; Durmishi, N.; Milovancevic, M. P.; Stefansson, H.; Schulze, T. G.; Nöthen, M. M.; Chen, C.; Lyne, R.; Morris, D. W.; Gill, M.; Corvin, A.; Zhang, D.; Dong, Q.; Moyzis, R. K.; Stefansson, K.; Sigurdsson, E.; Hu, F.; SCZ Consortium36, Consortium36; Su, B.; Gan, L.

In: Molecular Psychiatry, Vol. 19, No. 7, 2014, p. 774-783.

Research output: Contribution to journalArticle

Luo, XJ, Li, M, Huang, L, Steinberg, S, Mattheisen, M, Liang, G, Donohoe, G, Shi, Y, Chen, C, Yue, W, Alkelai, A, Lerer, B, Li, Z, Yi, Q, Rietschel, M, Cichon, S, Collier, DA, Tosato, S, Suvisaari, J, Rujescu, D, Golimbet, V, Silagadze, T, Durmishi, N, Milovancevic, MP, Stefansson, H, Schulze, TG, Nöthen, MM, Chen, C, Lyne, R, Morris, DW, Gill, M, Corvin, A, Zhang, D, Dong, Q, Moyzis, RK, Stefansson, K, Sigurdsson, E, Hu, F, SCZ Consortium36, C, Su, B & Gan, L 2014, 'Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility gene', Molecular Psychiatry, vol. 19, no. 7, pp. 774-783. https://doi.org/10.1038/mp.2013.103
Luo, X. J. ; Li, M. ; Huang, L. ; Steinberg, S. ; Mattheisen, M. ; Liang, G. ; Donohoe, G. ; Shi, Y. ; Chen, C. ; Yue, W. ; Alkelai, A. ; Lerer, B. ; Li, Z. ; Yi, Q. ; Rietschel, M. ; Cichon, S. ; Collier, D. A. ; Tosato, S. ; Suvisaari, J. ; Rujescu, Dan ; Golimbet, V. ; Silagadze, T. ; Durmishi, N. ; Milovancevic, M. P. ; Stefansson, H. ; Schulze, T. G. ; Nöthen, M. M. ; Chen, C. ; Lyne, R. ; Morris, D. W. ; Gill, M. ; Corvin, A. ; Zhang, D. ; Dong, Q. ; Moyzis, R. K. ; Stefansson, K. ; Sigurdsson, E. ; Hu, F. ; SCZ Consortium36, Consortium36 ; Su, B. ; Gan, L. / Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility gene. In: Molecular Psychiatry. 2014 ; Vol. 19, No. 7. pp. 774-783.
@article{f760e851187147f5a4da78dbff99f9f9,
title = "Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility gene",
abstract = "Genes that are differentially expressed between schizophrenia patients and healthy controls may have key roles in the pathogenesis of schizophrenia. We analyzed two large-scale genome-wide expression studies, which examined changes in gene expression in schizophrenia patients and their matched controls. We found calcium/calmodulin (CAM)-dependent protein kinase kinase 2 (CAMKK2) is significantly downregulated in individuals with schizophrenia in both studies. To seek the potential genetic variants that may regulate the expression of CAMKK2, we investigated the association between single-nucleotide polymorphisms (SNPs) within CAMKK2 and the expression level of CAMKK2. We found one SNP, rs1063843, which is located in intron 17 of CAMKK2, is strongly associated with the expression level of CAMKK2 in human brains (P=1.1 × 10-6) and lymphoblastoid cell lines (the lowest P=8.4 × 10-6). We further investigated the association between rs1063843 and schizophrenia in multiple independent populations (a total of 130 623 subjects) and found rs1063843 is significantly associated with schizophrenia (P=5.17 × 10 -5). Interestingly, we found the T allele of rs1063843, which is associated with lower expression level of CAMKK2, has a higher frequency in individuals with schizophrenia in all of the tested samples, suggesting rs1063843 may be a causal variant. We also found that rs1063843 is associated with cognitive function and personality in humans. In addition, protein-protein interaction (PPI) analysis revealed that CAMKK2 participates in a highly interconnected PPI network formed by top schizophrenia genes, which further supports the potential role of CAMKK2 in the pathogenesis of schizophrenia. Taken together, these converging lines of evidence strongly suggest that CAMKK2 may have pivotal roles in schizophrenia susceptibility.",
keywords = "association, CAMKK2, eQTL, expression, protein-protein interaction, schizophrenia",
author = "Luo, {X. J.} and M. Li and L. Huang and S. Steinberg and M. Mattheisen and G. Liang and G. Donohoe and Y. Shi and C. Chen and W. Yue and A. Alkelai and B. Lerer and Z. Li and Q. Yi and M. Rietschel and S. Cichon and Collier, {D. A.} and S. Tosato and J. Suvisaari and Dan Rujescu and V. Golimbet and T. Silagadze and N. Durmishi and Milovancevic, {M. P.} and H. Stefansson and Schulze, {T. G.} and N{\"o}then, {M. M.} and C. Chen and R. Lyne and Morris, {D. W.} and M. Gill and A. Corvin and D. Zhang and Q. Dong and Moyzis, {R. K.} and K. Stefansson and E. Sigurdsson and F. Hu and {SCZ Consortium36}, Consortium36 and B. Su and L. Gan",
year = "2014",
doi = "10.1038/mp.2013.103",
language = "English (US)",
volume = "19",
pages = "774--783",
journal = "Molecular Psychiatry",
issn = "1359-4184",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility gene

AU - Luo, X. J.

AU - Li, M.

AU - Huang, L.

AU - Steinberg, S.

AU - Mattheisen, M.

AU - Liang, G.

AU - Donohoe, G.

AU - Shi, Y.

AU - Chen, C.

AU - Yue, W.

AU - Alkelai, A.

AU - Lerer, B.

AU - Li, Z.

AU - Yi, Q.

AU - Rietschel, M.

AU - Cichon, S.

AU - Collier, D. A.

AU - Tosato, S.

AU - Suvisaari, J.

AU - Rujescu, Dan

AU - Golimbet, V.

AU - Silagadze, T.

AU - Durmishi, N.

AU - Milovancevic, M. P.

AU - Stefansson, H.

AU - Schulze, T. G.

AU - Nöthen, M. M.

AU - Chen, C.

AU - Lyne, R.

AU - Morris, D. W.

AU - Gill, M.

AU - Corvin, A.

AU - Zhang, D.

AU - Dong, Q.

AU - Moyzis, R. K.

AU - Stefansson, K.

AU - Sigurdsson, E.

AU - Hu, F.

AU - SCZ Consortium36, Consortium36

AU - Su, B.

AU - Gan, L.

PY - 2014

Y1 - 2014

N2 - Genes that are differentially expressed between schizophrenia patients and healthy controls may have key roles in the pathogenesis of schizophrenia. We analyzed two large-scale genome-wide expression studies, which examined changes in gene expression in schizophrenia patients and their matched controls. We found calcium/calmodulin (CAM)-dependent protein kinase kinase 2 (CAMKK2) is significantly downregulated in individuals with schizophrenia in both studies. To seek the potential genetic variants that may regulate the expression of CAMKK2, we investigated the association between single-nucleotide polymorphisms (SNPs) within CAMKK2 and the expression level of CAMKK2. We found one SNP, rs1063843, which is located in intron 17 of CAMKK2, is strongly associated with the expression level of CAMKK2 in human brains (P=1.1 × 10-6) and lymphoblastoid cell lines (the lowest P=8.4 × 10-6). We further investigated the association between rs1063843 and schizophrenia in multiple independent populations (a total of 130 623 subjects) and found rs1063843 is significantly associated with schizophrenia (P=5.17 × 10 -5). Interestingly, we found the T allele of rs1063843, which is associated with lower expression level of CAMKK2, has a higher frequency in individuals with schizophrenia in all of the tested samples, suggesting rs1063843 may be a causal variant. We also found that rs1063843 is associated with cognitive function and personality in humans. In addition, protein-protein interaction (PPI) analysis revealed that CAMKK2 participates in a highly interconnected PPI network formed by top schizophrenia genes, which further supports the potential role of CAMKK2 in the pathogenesis of schizophrenia. Taken together, these converging lines of evidence strongly suggest that CAMKK2 may have pivotal roles in schizophrenia susceptibility.

AB - Genes that are differentially expressed between schizophrenia patients and healthy controls may have key roles in the pathogenesis of schizophrenia. We analyzed two large-scale genome-wide expression studies, which examined changes in gene expression in schizophrenia patients and their matched controls. We found calcium/calmodulin (CAM)-dependent protein kinase kinase 2 (CAMKK2) is significantly downregulated in individuals with schizophrenia in both studies. To seek the potential genetic variants that may regulate the expression of CAMKK2, we investigated the association between single-nucleotide polymorphisms (SNPs) within CAMKK2 and the expression level of CAMKK2. We found one SNP, rs1063843, which is located in intron 17 of CAMKK2, is strongly associated with the expression level of CAMKK2 in human brains (P=1.1 × 10-6) and lymphoblastoid cell lines (the lowest P=8.4 × 10-6). We further investigated the association between rs1063843 and schizophrenia in multiple independent populations (a total of 130 623 subjects) and found rs1063843 is significantly associated with schizophrenia (P=5.17 × 10 -5). Interestingly, we found the T allele of rs1063843, which is associated with lower expression level of CAMKK2, has a higher frequency in individuals with schizophrenia in all of the tested samples, suggesting rs1063843 may be a causal variant. We also found that rs1063843 is associated with cognitive function and personality in humans. In addition, protein-protein interaction (PPI) analysis revealed that CAMKK2 participates in a highly interconnected PPI network formed by top schizophrenia genes, which further supports the potential role of CAMKK2 in the pathogenesis of schizophrenia. Taken together, these converging lines of evidence strongly suggest that CAMKK2 may have pivotal roles in schizophrenia susceptibility.

KW - association

KW - CAMKK2

KW - eQTL

KW - expression

KW - protein-protein interaction

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84908650212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908650212&partnerID=8YFLogxK

U2 - 10.1038/mp.2013.103

DO - 10.1038/mp.2013.103

M3 - Article

VL - 19

SP - 774

EP - 783

JO - Molecular Psychiatry

JF - Molecular Psychiatry

SN - 1359-4184

IS - 7

ER -